Skip to content

Insulet PODD Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Medtronic logo
MedtronicMDT
$97M-10.2%
AptarGroup logo
AptarGroupATR
$18.52M+449%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$5.5M+120%
Abbott logo
AbbottABT
$116M-59.6%
Viatris logo
ViatrisVTRS
$500K-16.7%

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's stock issuance proceeds?
Insulet (PODD) reported stock issuance proceeds of $400K in Q1 2026.
How has Insulet's stock issuance proceeds changed year-over-year?
Insulet's stock issuance proceeds decreased by 84.0% year-over-year, from $2.5M to $400K.
What does stock issuance proceeds mean?
Cash received from selling new shares of company stock.
How do you interpret stock issuance proceeds?
Higher proceeds indicate successful capital raising or high employee participation in equity programs, while lower proceeds may reflect reduced reliance on equity financing.
How does stock issuance proceeds compare across companies?
Standard for growth-stage companies or those with significant employee equity compensation programs.